Amyotrophic Lateral Sclerosis Disease: Analytical Methods of Measurement of Therapeutic Agents against the Disease in Biological Fluids

Mbah, C. J.

Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria

Dr. Mbah, C. J., Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria.

Keywords: Sclerosis; Biological Fluids; Hyphenated HPLC


Amyotrophic lateral sclerosis (ALS) is an irreversible most common motor neuron disease in which the upper and lower motor neurons in the motor cortex, brain stem and spinal cord degenerate leading to progressive paralysis and death probably arising from respiratory failure [1-3].
The disease is caused by genetic mutations [4,5], oxidative stress [6], inflammation [7], loss of neurotrophic factors [8], glutamate excitotoxicity [9], mitochondrial dysfunction [10].
Alpha-amino-3-hydroxy-5- methyl-4-isoxazole propionic acid (AMPA) receptors mediate glutamateinduced excitotoxicity in neurodegenerative diseases [11].

View Full Text | Download PDF

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Total Articles Published


Total Citations:



Cient Periodique is a ‘Gold’ open access publisher that aspires to offer absolute free, unrestricted access to the valuable research information

We welcome all the eminent authors to submit your valuable paper

Cient Periodique invites the participation of honourable Editors and Authors

CPQ Journals provide Certificates for publication

Cient Periodique also offers memberships for potential Authors

Best Articles will be appreciated with the provision of corresponding Certificate